title: Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.
authors.affiliation: Department of Medicine, Oregon Health Sciences University, Portland 97207, USA.
authors.forename: H R
authors.initials: HR
authors.lastname: Rosen
authors.forename: K G
authors.initials: KG
authors.lastname: Benner
authors.forename: K D
authors.initials: KD
authors.lastname: Flora
authors.forename: J M
authors.initials: JM
authors.lastname: Rabkin
authors.forename: S L
authors.initials: SL
authors.lastname: Orloff
authors.forename: A
authors.initials: A
authors.lastname: Olyaei
authors.forename: S
authors.initials: S
authors.lastname: Chou
mesh_terms: D000293:Adolescent; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D004252:DNA Mutational Analysis; D004352:Drug Resistance, Microbial / Q000235:genetics; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male
chemical_list: D017245:Foscarnet; D015774:Ganciclovir